CANY
NVRO

Caxton Associates (New York)’s NEVRO CORP. NVRO Stock Holding History

Caxton Associates (New York)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,970
Closed -$408K – 602
2023
Q4 		$408K Buy
+18,970
New +$338K 0.02% 349
2020
Q1 		– Sell
-2,524
Closed -$297K – 625
2019
Q4 		$297K Buy
+2,524
New +$250K 0.04% 281

Other funds holding NVRO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Caxton Associates (New York)'s NVRO Position: Q1 2024 in Review

Caxton Associates (New York) sold out of NEVRO CORP. (NVRO) in Q1 2024, closing a stake of 18,970 shares — an estimated $408K sold.

Caxton Associates (New York) first reported a position in NVRO in Q4 2019 and held it in 2 quarters. The position peaked at $408K in Q4 2023. 153 funds tracked by Wall St. Rank hold NVRO as of Q1 2024.

  • Caxton Associates (New York) reported no remaining NEVRO CORP. position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 18,970 NEVRO CORP. shares in Q1 2024, an estimated $408K.
  • Caxton Associates (New York) first reported a position in NEVRO CORP. in Q4 2019 and held it in 2 quarters.
  • Caxton Associates (New York)'s NEVRO CORP. position peaked at $408K in Q4 2023.
  • 153 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.